Rourou S - Search Results

1

Analytical Methods for Evaluating the Immunogenicity of Recombinant Rabies Virus Glycoprotein Expressed in the Yeast Komagataella phaffii.

Askri H, Kallèl H, Rourou S, Snoussi MA, Lachheb J. Askri H, et al. Among authors: rourou s. Immunol Invest. 2024 Nov;53(8):1308-1329. doi: 10.1080/08820139.2024.2399589. Epub 2024 Sep 9. Immunol Invest. 2024. PMID: 39252192

2

Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.

Rourou S, Ben Zakkour M, Kallel H. Rourou S, et al. Vaccine. 2019 Nov 8;37(47):6987-6995. doi: 10.1016/j.vaccine.2019.05.092. Epub 2019 Jun 11. Vaccine. 2019. PMID: 31201054 Free article.

3

Production, purification, and characterization of recombinant rabies virus glycoprotein expressed in PichiaPink™ yeast.

Askri H, Akrouti I, Rourou S, Kallèl H. Askri H, et al. Among authors: rourou s. Biotechnol Rep (Amst). 2022 May 13;35:e00736. doi: 10.1016/j.btre.2022.e00736. eCollection 2022 Sep. Biotechnol Rep (Amst). 2022. PMID: 35646619 Free PMC article.

4

Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine.

Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, Rourou S, Dellagi K. Kallel H, et al. Among authors: rourou s. Vaccine. 2006 May 29;24(22):4856-62. doi: 10.1016/j.vaccine.2006.03.012. Epub 2006 Mar 20. Vaccine. 2006. PMID: 16600442

5

Development of an Optimized Process for Functional Recombinant SARS-CoV-2 Spike S1 Receptor-Binding Domain Protein Produced in the Baculovirus Expression Vector System.

Boumaiza M, Chaabene A, Akrouti I, Ben Zakour M, Askri H, Salhi S, Ben Hamouda W, Marzouki S, Benabdessalem C, Ben Ahmed M, Trabelsi K, Rourou S. Boumaiza M, et al. Among authors: rourou s. Trop Med Infect Dis. 2023 Nov 16;8(11):501. doi: 10.3390/tropicalmed8110501. Trop Med Infect Dis. 2023. PMID: 37999620 Free PMC article.

6

Development of an efficient veterinary rabies vaccine production process in the avian suspension cell line AGE1.CR.pIX.

Trabelsi K, Zakour MB, Jordan I, Sandig V, Rourou S, Kallel H. Trabelsi K, et al. Among authors: rourou s. BMC Biotechnol. 2022 Jun 17;22(1):17. doi: 10.1186/s12896-022-00747-5. BMC Biotechnol. 2022. PMID: 35715843 Free PMC article.

7

Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.

Kallel H, Jouini A, Majoul S, Rourou S. Kallel H, et al. Among authors: rourou s. J Biotechnol. 2002 May 23;95(3):195-204. doi: 10.1016/s0168-1656(02)00009-3. J Biotechnol. 2002. PMID: 12007860

8

Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.

Trabelsi K, Rourou S, Loukil H, Majoul S, Kallel H. Trabelsi K, et al. Among authors: rourou s. J Biotechnol. 2006 Jan 24;121(2):261-71. doi: 10.1016/j.jbiotec.2005.07.018. Epub 2005 Sep 8. J Biotechnol. 2006. PMID: 16153733

9

A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.

Rourou S, van der Ark A, van der Velden T, Kallel H. Rourou S, et al. Vaccine. 2007 May 10;25(19):3879-89. doi: 10.1016/j.vaccine.2007.01.086. Epub 2007 Feb 5. Vaccine. 2007. PMID: 17307281

10

A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor.

Rourou S, van der Ark A, Majoul S, Trabelsi K, van der Velden T, Kallel H. Rourou S, et al. Appl Microbiol Biotechnol. 2009 Nov;85(1):53-63. doi: 10.1007/s00253-009-2064-y. Epub 2009 Jun 12. Appl Microbiol Biotechnol. 2009. PMID: 19521697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters